PacBio to commence commercial shipment of Revio Systems
Mar. 07, 2023 7:43 AM ETPacific Biosciences of California, Inc. (PACB)By: Khyathi Dalal, SA News Editor1 Comment
- PacBio (NASDAQ:PACB) announced the first customer shipments of Revio long-read sequencing systems, featuring significant advances in SMRT Cell design, compute, and system architecture, will commence on Mar.8, 2023.
- Together, this enables a dramatic increase in throughput and lower sequencing costs with the trusted power of HiFi chemistry, which offers exceptional accuracy and direct methylation detection.
- Revio systems will be shipped worldwide, with Mohammed Bin Rashid University of Medicine and Health Sciences set to expand their large-scale research projects with Revio.
- Additional Revio systems will also be shipped to customers in China, Japan, Korea, Netherlands, and Sweden.
- The company announced orders of 76 Revio systems in the quarter ended Dec.31, 2022 and expects to ship at least 25 Revio systems during Q1 of 2023.